Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells 30,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $13.61, for a total value of $408,300.00. Following the transaction, the president now owns 1,606,097 shares of the company’s stock, valued at $21,858,980.17. This trade represents a 1.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Friday, November 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $11.35, for a total transaction of $340,500.00.

Alignment Healthcare Trading Up 0.2 %

Shares of Alignment Healthcare stock opened at $14.58 on Friday. The stock has a market capitalization of $2.79 billion, a PE ratio of -18.94 and a beta of 1.45. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $14.79. The stock has a 50 day moving average price of $11.94 and a two-hundred day moving average price of $10.78. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, meeting analysts’ consensus estimates of ($0.14). Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The business had revenue of $692.43 million during the quarter, compared to analyst estimates of $662.11 million. During the same quarter in the previous year, the business posted ($0.19) EPS. Alignment Healthcare’s quarterly revenue was up 51.6% on a year-over-year basis. As a group, equities analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Alignment Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the business. SG Americas Securities LLC boosted its stake in Alignment Healthcare by 11.7% during the 4th quarter. SG Americas Securities LLC now owns 49,272 shares of the company’s stock valued at $554,000 after purchasing an additional 5,163 shares during the last quarter. Ballentine Partners LLC bought a new stake in Alignment Healthcare during the fourth quarter worth $121,000. JPMorgan Chase & Co. grew its holdings in Alignment Healthcare by 249.3% during the third quarter. JPMorgan Chase & Co. now owns 288,219 shares of the company’s stock worth $3,407,000 after buying an additional 205,705 shares in the last quarter. Principal Financial Group Inc. raised its position in Alignment Healthcare by 1,335.1% in the 3rd quarter. Principal Financial Group Inc. now owns 194,043 shares of the company’s stock valued at $2,294,000 after buying an additional 180,522 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in shares of Alignment Healthcare by 1.4% in the third quarter. Geode Capital Management LLC now owns 2,442,447 shares of the company’s stock valued at $28,875,000 after purchasing an additional 32,839 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Wall Street Analysts Forecast Growth

ALHC has been the topic of a number of recent analyst reports. Stephens reaffirmed an “overweight” rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research note on Thursday, January 2nd. UBS Group boosted their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a report on Wednesday, October 30th. Barclays increased their price target on Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 30th. Stifel Nicolaus boosted their price objective on Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Tuesday, January 14th. Finally, KeyCorp assumed coverage on Alignment Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating for the company. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.